Intelligence Profile
Research Papers
Research Papers and Clinical Trials
The available evidence on enclomiphene consists primarily of recent review articles, position statements, and small case series, with limited large-scale clinical trial data specifically for this compound.
Systematic Reviews and Meta-Analyses
A 2025 systematic review and meta-analysis published in Archives of Endocrinology and Metabolism examined randomized controlled trials comparing clomiphene or enclomiphene citrate for treating male hypogonadism. This review generated significant academic discussion, with multiple letters to the editor and responses published in the same journal, suggesting ongoing debate about the comparative effectiveness of these treatments.
Clinical Case Series
A small retrospective case series published in Cureus (2025) evaluated sublingual enclomiphene citrate combined with a mineral oxide delivery system in 15 men, examining changes in serum testosterone levels. However, the limited sample size restricts the generalizability of these findings.
Position Statements and Reviews
The British Society of Sexual Medicine published a position statement in 2026 regarding the potential use of enclomiphene for treating male hypogonadism, indicating growing clinical interest in this application. Additionally, a comprehensive review in Translational Andrology and Urology (2025) discussed innovations in testosterone replacement and stimulatory therapies, including approaches to preserve spermatogenesis in testosterone-deficient men.
Clinical Trial Landscape
The clinical trials database shows limited studies specifically investigating enclomiphene. Most registered trials focus on clomiphene citrate for ovulation induction in women with polycystic ovary syndrome (PCOS), with phases ranging from early Phase 1 to Phase 4 studies. However, these trials do not directly address enclomiphene's use in male hypogonadism.
Limitations
The current evidence base for enclomiphene is relatively thin, consisting mainly of small case series, review articles, and position statements rather than large-scale randomized controlled trials. More robust clinical data is needed to establish definitive efficacy and safety profiles for this compound.
This information is for educational purposes only and should not replace professional medical advice. Consult a healthcare provider for personalized treatment recommendations.